Description
Introduction
Campto 40mg Injection helps in the treatment of cancer. The drug prevents the multiplication and spread of cancer cells. Medical professionals use this drug to treat cancer of the colon or rectum. It is specifically a combination drug, and is prescribed with other cancer medicines during chemotherapy.
Before the doctor begins chemotherapy using this drug, provide him with a detailed medical history. Inform him about any current problems that you may be suffering from, especially if you have kidney or liver issues, diabetes, Gilbert’s syndrome, asthma or intestinal problems. The drug is not meant to be used in cancer treatment for women patients who are pregnant. Breast feeding mothers should also consult their doctor before starting treatment.
A DNA test may be done before the treatment commences. It is generally administered via an IV for about 90 minutes.
The most common side effect of Campto 100mg Injection is diarrhea, which can even become life threatening if it leads to dehydration. Doctors generally subscribe medicines to prevent the onset of this side effect. Other side effects include- anxiety, chills, confusion, tightness or pain in the chest, cough and hoarse voice, fever, dizziness etc.
Some very rare side effects that one may experience are hives, sudden gain weight, rise in blood pressure and swelling of the face, eyes and lips.
Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.
Disclaimer:
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.
Reviews
There are no reviews yet.